- Home
- FPH vs FENC Comparison
FPH vs FENC Comparison
Compare FPH & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FPH | FENC |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.2M | 411.0M |
| IPO Year | 2013 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FPH | FENC |
|---|---|---|
| Price | $5.13 | $11.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | ★ 187.3K | 171.1K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $110,020,000.00 | $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | ★ $11.40 | $189.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.60 | $5.65 |
| 52 Week High | $6.64 | $13.25 |
Technical Indicators
Market Signals| Indicator | FPH | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 53.87 |
| Support Level | $4.89 | $9.74 |
| Resistance Level | $5.16 | N/A |
| Average True Range (ATR) | 0.13 | 0.69 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 14.52 | 49.05 |
Price Performance
Historical ComparisonAbout FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.